Wounds That Would Not Heal: Pyoderma Gangrenosum - 20/03/18
Doi : 10.1016/j.amjmed.2017.12.009
Joanie Pinard, MD, FRCPC a, David Y. Chiang, MD, PhD b, Arash Mostaghimi, MD, MPA, MPH a, b, Scott R. Granter, MD c, Joseph F. Merola, MD, MMsc a, b, Ebrahim Barkoudah, MD, MPH b, * 
a Department of Dermatology
b Department of Medicine
c Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass
*Requests for reprints should be addressed to Ebrahim Barkoudah, MD, MPH, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115.Brigham and Women's Hospital75 Francis StreetBostonMA02115
Thomas J. Marrie, MD, Section Editor
Le texte complet de cet article est disponible en PDF.Plan
| Funding: There was no funding for this article. |
|
| Conflicts of Interest: There are no potential conflicts of interest, real or perceived, related to this work. DYC, AM, SRG, and EB have no relevant financial interests to report. JP serves as consultant/advisor for Celgene and Janssen Canada. JFM serves as consultant/advisor for Biogen IDEC, AbbVie, Amgen, Eli Lilly, Novartis, Pfizer, Janssen, UCB, Kiniksa, Momenta, and Mallinckrodt. |
|
| Authorship: All authors had full access to all of the medical data pertaining to the reported paper and take responsibility for the integrity and the accuracy of the data report and literature review. |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 131 - N° 4
P. 377-379 - avril 2018 Retour au numéro
Article précédent
- No More ‘Code Black’: Intervention to Improve Inpatient Flow at a Large Public Hospital
- Charles E. Coffey, Valda Carter, Eric Wei, Douglass Hutcheon, John P. Gruen, Annie Anonas-Ternate, Rebecca Sandoval, Annie Marquez, Laura Sarff, Brad Spellberg
- Site-Seeing: Hereditary Hemorrhagic Telangiectasia with Native-Valve Endocarditis
- Teiko Kawahigashi, Sho Nishiguchi, Joel Branch, Kazuki Hiramitsu, Takayuki Niitsu, Izumi Kitagawa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?